Fusion Rates of Patients Treated with rhBMP-2 - Spine ...


Published on

1 Like
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Fusion Rates of Patients Treated with rhBMP-2 - Spine ...

  1. 1. Fusion Rates of Patients Treated with rhBMP-2 (Infuse) in Primary Multilevel Posterolateral Lumbar Fusion Surgery Michael Rivlin; Marjorie M. Mariller, MD, MPH; Chan Roonprapunt, MD, PhD; Catherine N. Petchprapa, MD; Kevin Math, MD; Fabien D. Bitan, MD; Andrew M. Casden, MD; Michael G. Neuwirth, MD; Paul Kuflik, MD, FAAOS The Spine Institute of New York at Beth Israel Medical Center Presented at IMAST 13th Annual Scientific Meeting
  2. 2. Background • Spinal orthopedic surgery often requires the fusion of multiple vertebrae in order to ensure fixation of the axial spine. • Indication of spinal fusion or arthrodesis are: – cases that have increased axial instability or deformity that has a high probability of progressing. – degenerative disorders of the spine – curvature deformity – vertebral fractures – herniated nucleus pulposus – Spondylolisthesis – pseudoarthroses
  3. 3. Background • Fusion can be achieved using different grafts and devices i.e. – autologous grafts harvested from the patients iliac crests – allografts, synthetic materials that enhance bone growth (often complemented with instrumentation to insure stability) • The rates of fusion following an instrumented posterolateral fusion with autograft vary from 43% to 83% and from 66% to 75% for 2-level fusions and 3- level fusions, respectively.
  4. 4. Objective • To determine the fusion rate of patients treated with BMP undergoing multilevel posterolateral lumbar fusions.
  5. 5. Materials • Bone Morphogenetic Proteins (BMP) are cytokines that belong to a family of TGF-beta superproteins. There are 15 BMPs identified (BMP-2 is used in the present study). • BMP functions include: – the induction of bone and cartilage formation due to which they were named after – maturation of osteocytes, chondroblasts, osteoblasts – implicated in the process of angiogenesis in bone
  6. 6. Materials • Recombinant techniques have enabled scientists to purify BMP (rhBMP) free from potentially infectious materials • It is packaged in a collagen (type I) sponge containing rhBMP and it is often applied with fusion cage systems. • Preparation of the implant is performed intraoperatively by combining the BMP infused collagen sponge and the Mastergraft.
  7. 7. Materials Mastergraft addedMastergraft added Radiograph of the prepared implant Implant to be usedImplant to be used Rolled into shapeRolled into shape BMP infused collagen spongeBMP infused collagen sponge
  8. 8. Methods • In a retrospective review of patients operated at the Spine Institute, we identified 28 patients who had undergone primary two- or three level lumbar fusion with rhBMP-2 for degenerative conditions, such as stenosis, spondylolisthesis, and degenerative disc disease. • The cases of tumor, infection, or trauma were excluded. • No patients had iliac bone crest harvested. • The patients were retrospectively followed up at 3, 6, 12 and when available, 24 months.
  9. 9. Methods
  10. 10. Methods • The diagnosis of pseudarthrosis was determined by plain X-rays and scored by independent radiologists using the posterior fusion grading system developed by Lenke et al. • Fusion was graded on a scale of 1 to 4 Levels - grade 1 or 2 were considered as fused. • Fusion was achieved by placing BMP graft over the lateral recess of the exposed and decompressed (laminectomy) spine. The graft was placed over the decorticated bleeding bone.
  11. 11. Grade 1: Bilateral solid fusion Grade 2: Unilateral solid fusion, partial fusion contralaterally Grade 3: Partial graft resorption with no clear fusion Grade 4: Bilateral graft resorption with no evidence of fusion Methods Radiographic Criteria for Fusion
  12. 12. Results Descriptive data • 68% of the patients included in the study were women. The patients’ mean age was 61 years old (range 33-80). The degenerative conditions that were treated included lumbar stenosis (79%), spondylolisthesis (71%) and degenerative disc disease (32%).
  13. 13. Results Statistics of Patients # of Pts % Smoking 3 11% Osteopenia 5 21% Diabetes 2 7% Regular alcohol users 11 39% Preoperative NSAIDS 19 68% Preoperative narcotics 12 43% Prior spine surgery 2 7% Neurological symptoms 6 22% Functional defects 1 4% Physical therapy 14 54% Worker’s compensation 4 17%
  14. 14. Results BMI # of Pts. % Normal 7 25% Overweight 11 39% Obese 9 32% Morbidly obese 1 4%
  15. 15. Results Surgical data • All twenty eight patients had undergone a decompressive laminectomy, and instrumented posterolateral fusion with BMP placement. • The average amount of BMP placed was 9.4 micrograms per levels fused. • Twenty-five patients underwent a 2-level fusion and three patients underwent a 3-level fusion. • Local bone was used in half of the patients.
  16. 16. Results Outcomes # of Pts Mean (95% CI) Length of surgery (hh:mm) 28 4:10 (3:52-4:28) EBL (ml) 27 637 (527-747) Cell saver (ml) 28 114 (71-157) Hospital stay (days)* 27 6.55 (5.84-7.26) Complications # of Pts Infection, return to OR 2 Infection 2 DVT 1
  17. 17. Results Transfusion • Two out of the 28 patients received a blood transfusion (they received one and two units of blood, respectively). Risk factors • Preoperative narcotic use was associated with lower fusion rates (p=0.002); all patients without previous narcotic use had a solid fusion. There was no association between the fusion rate and the following factors: smoking (p=0.107); preOp NSAIDS (p=0.630); BMI (p= 0.232); and regular consumption of alcohol (p=0.174).
  18. 18. Results Fusion rate • The fusion rate per level was 83% at last follow-up (mean follow- up period was 12 months). Seventy nine percent of the patients achieved fusion at all levels. Half of the failures achieved partial fusion.
  19. 19. Results Overall Fusion Rate (per level)
  20. 20. Conclusions • Fusion rates of patients treated with rhBMP-2 in primary multilevel posterolateral lumbar surgery were similar to historic fusion rates reported for multilevel instrumented arthrodesis using autogenous bone graft. Therefore, rhBMP-2 represents a good option for obtaining successful multilevel lumbar arthrodesis without the associated historical graft site morbidity.
  21. 21. Conclusions • As a future investigation, we plan: – To measure the clinical and radiological outcomes of BMP fusion for different surgical approaches (posterior, anterior, lateral, etc) – To focus also on the risk factors as confounders, such as the effect of smoking and NSAIDs, to observe the effect these play on the outcomes.